James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.

Oregon Health and Sciences University’s Eric Gouaux, PhD, discussed mechanisms of signal transduction and clearance at the chemical synapses of the brain during his recent Flexner Discovery Lecture.

Eric Gouaux, PhD, whose work has helped reveal the molecular mechanisms by which nerve cells communicate, will deliver the next Flexner Discovery Lecture Thursday, Feb. 22.

Bruce Gelb, MD, an expert on congenital heart defects, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 8.

Clinical trials expert Roger Lewis, MD, PhD, right, poses with Vanderbilt’s Yu Shyr, MD, following his recent Discovery Lecture. Lewis is chair of Emergency Medicine at Harbor-UCLA Medical Center in Los Angeles.

Roger Lewis, MD, PhD, a national expert on methods that can improve the flexibility and efficiency of clinical trials, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 4, 2018.

Basic research underway at Vanderbilt University Medical Center is raising hopes that one day it will be possible to reverse memory loss in people with Alzheimer’s disease and stop a major driver of cancer in its tracks.